Tharimmune (THAR) Stock Chart & Stock Price History $2.61 +0.11 (+4.40%) (As of 11/21/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Tharimmune Stock Price Performance 5 Day Performance+20.28%1 Month Performance+26.09%3 Month Performance-11.82%6 Month Performance-46.63%Year-To-Date Performance-65.82%1 Year Performance-94.24% Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address Central Bank Abandons USD (Ad)You know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our exploding national debt, VOTE FOR GOLD! Get Your FREE Gold Investor Kit NOW! THAR Stock Chart for Friday, November, 22, 2024 THAR Chart by TradingView Tharimmune Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/21/2024$2.50$2.61+4.40%$2.73$2.36101,699 shs$3.89 million11/20/2024$2.43$2.50+2.88%$2.59$2.30173,306 shs$3.73 million11/19/2024$2.37$2.43+2.53%$2.56$2.18221,014 shs$3.62 million11/18/2024$2.17$2.37+9.22%$2.42$1.858.74 million shs$3.52 million11/15/2024$2.23$2.17-2.69%$2.31$2.1268,537 shs$3.23 million11/14/2024$2.13$2.23+4.69%$2.29$2.10166,984 shs$3.31 million Get the Latest News and Ratings for THAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024$2.15$2.13-0.93%$2.33$1.901.27 million shs$3.17 million11/12/2024$2.26$2.15-4.87%$2.30$2.15108,997 shs$2.47 million11/11/2024$2.37$2.26-4.64%$2.32$2.2154,221 shs$2.60 million11/08/2024$2.43$2.37-2.47%$2.47$2.2661,056 shs$2.73 million11/07/2024$2.80$2.43-13.21%$2.83$2.34100,746 shs$2.79 million11/06/2024$2.77$2.80+1.08%$2.95$2.76159,341 shs$3.22 million11/05/2024$2.95$2.77-6.10%$2.99$2.74109,171 shs$3.18 million11/04/2024$2.69$2.95+9.67%$3.06$2.45201,398 shs$3.39 million11/01/2024$2.85$2.69-5.61%$3.17$2.66385,801 shs$3.09 million10/31/2024$3.43$2.85-16.91%$3.30$2.511.10 million shs$2.24 million10/30/2024$2.03$3.43+68.97%$6.28$3.0861.25 million shs$2.70 million10/29/2024$1.98$2.03+2.53%$2.04$1.8937,923 shs$1.60 million10/28/2024$1.95$1.98+1.54%$2.00$1.8541,284 shs$1.56 million10/25/2024$2.00$1.95-2.50%$2.05$1.8943,796 shs$1.53 million10/24/2024$2.05$2.00-2.44%$2.10$1.9833,728 shs$1.57 million10/23/2024$2.07$2.05-0.97%$2.20$2.0025,721 shs$1.61 million10/22/2024$2.14$2.07-3.27%$2.14$2.0515,668 shs$1.63 million10/21/2024$2.19$2.14-2.28%$2.28$2.0432,717 shs$1.68 million Related Companies Minerva Neurosciences Stock Chart TherapeuticsMD Stock Chart Bright Green Stock Chart Akari Therapeutics Stock Chart IN8bio Stock Chart NRx Pharmaceuticals Stock Chart Kazia Therapeutics Stock Chart AIM ImmunoTech Stock Chart PharmaCyte Biotech Stock Chart Sol-Gel Technologies Stock Chart Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:THAR) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
